1. Home
  2. DOMO vs ARMP Comparison

DOMO vs ARMP Comparison

Compare DOMO & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$3.91

Market Cap

132.7M

Sector

Technology

ML Signal

HOLD

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$4.63

Market Cap

156.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DOMO
ARMP
Founded
2010
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.7M
156.4M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
DOMO
ARMP
Price
$3.91
$4.63
Analyst Decision
Buy
Strong Buy
Analyst Count
9
2
Target Price
$10.28
$15.00
AVG Volume (30 Days)
2.2M
161.2K
Earning Date
05-20-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
31.92
N/A
EPS
N/A
N/A
Revenue
$318,857,000.00
N/A
Revenue This Year
$3.41
N/A
Revenue Next Year
$4.72
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.57
N/A
52 Week Low
$1.84
$2.36
52 Week High
$18.49
$14.98

Technical Indicators

Market Signals
Indicator
DOMO
ARMP
Relative Strength Index (RSI) 56.51 43.62
Support Level $3.22 $3.48
Resistance Level $3.99 $5.50
Average True Range (ATR) 0.28 0.54
MACD 0.02 0.10
Stochastic Oscillator 50.77 25.47

Price Performance

Historical Comparison
DOMO
ARMP

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: